WellQuestPro is a clinician-centered longitudinal intelligence platform for licensed healthcare professionals in oncology, urology, and primary care. Unlike point-in-time clinical AI tools, WellQuestPro tracks patients across every encounter — surfacing what changed since the last visit, what has worsened over time, and what still lacks follow-up.
What makes WellQuestPro different
Every clinical AI platform answers the question in front of the clinician. WellQuestPro answers the questions the clinician didn't know to ask — because it remembers the last six months, not just today's chief complaint.
Core capabilities
Evidence-linked reasoning — Every recommendation surfaces its source: the peer-reviewed trial, the guideline version, and the patient context that triggered the flag. Citations verified against PubMed in real time. Clinicians see the evidence, not just the conclusion.
Deep medication safety — Drug safety checks reflect the actual patient: eGFR, live labs, allergy history, comorbidity burden. Not a generic drug-pair lookup. Patient-specific contraindications, renal/hepatic dose adjustments, and therapeutic alternatives surface automatically.
AI clinical documentation — Notes are generated from the reasoning engine, not a generic template. The note reflects the evidence, patient flags, and clinical rationale. Clinicians review and edit; AI drafts from the logic already in the session.
Care gap detection — Identifies what should have happened and didn't: unresolved abnormal labs, overdue surveillance imaging, outstanding referrals, and preventive care gaps tied to diagnosis and age.
Specialty depth — Oncology (NCCN-aligned, clinical evidence reviewed by Prof. Kunle Odunsi, Director, University of Chicago Comprehensive Cancer Center), urology, and primary care/internal medicine.
Security & compliance
HIPAA-compliant · BAA on all paid plans · AES-256 at rest · TLS 1.3 in transit · SOC 2 Type II in progress (Q3 2026) · AWS data residency · RBAC, MFA, SSO on Enterprise
Pricing
Five plans: $149–$499/provider/month. LMIC global access tier: $29–$79/provider/month (PPP-adjusted, 137 countries) — the only premium clinical AI platform with dedicated pricing for low- and middle-income country healthcare systems. 30-day free trial on all plans.
Founded by Dr. Adebowale Awosika-Olumo, MD, MS, MPH, PhD, FACE — NCI, CDC & NIH collaborator · Fellow, American College of Epidemiology · Professor, University of Maryland Global Campus.
WellQuestPro is designed to support licensed healthcare professionals and care teams. It does not replace independent clinical judgment, diagnosis, or treatment decisions.
